GALDERMA PHARMA SA has a total of 41 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, environmental technology and medical technology are SIGMOID BIOTECHNOLOGIES LTD, SIGMOID PHARMA LTD and BIOENVISION INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 5 | |
#4 | Hong Kong | 4 | |
#5 | Australia | 3 | |
#6 | China | 3 | |
#7 | Hungary | 3 | |
#8 | France | 2 | |
#9 | Brazil | 1 | |
#10 | Luxembourg | 1 | |
#11 | Mexico | 1 | |
#12 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Climate change adaptation technologies | |
#4 | Diagnosis and surgery | |
#5 | Electrotherapy |
# | Name | Total Patents |
---|---|---|
#1 | Rossi Thomas M | 13 |
#2 | Dejovin Jack A | 10 |
#3 | Andres Philippe | 8 |
#4 | Mallard Claire | 8 |
#5 | Willcox Nathalie | 8 |
#6 | Graeber Michael | 7 |
#7 | Loesche Christian | 7 |
#8 | Scherer Warren J | 6 |
#9 | Dejovin Jack | 5 |
#10 | Touitou Elka | 2 |
Publication | Filing date | Title |
---|---|---|
AU2010313643A1 | Methods of treating or preventing acute erythema | |
WO2010086727A1 | Stable compositions for nail onychomycosis treatment | |
FR2954164A1 | ANTIFUNGAL COMPOSITION INTENDED TO BE APPLIED ON THE PERFORATED NAIL | |
FR2954163A1 | USE OF A CATIONIC SURFACTANT, ADVANTAGEU-SEMENT AMPHOTERE, FOR THE PREPARATION OF AN ANTIFUNGAL COMPOSITION APPLICABLE ON THE NATIVE | |
AU2005247467A1 | Compounds, formulations, and methods for treating or preventing inflammatory skin disorders | |
EP1789433A2 | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |